Versant Capital Management’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18K | Buy |
1,286
+570
| +80% | +$7.97K | ﹤0.01% | 1590 |
|
|
2025
Q1 | $9.73K | Buy |
716
+513
| +253% | +$6.97K | ﹤0.01% | 1739 |
|
|
2024
Q4 | $4.14K | Hold |
203
| – | – | ﹤0.01% | 1848 |
|
|
2024
Q3 | $5.91K | Buy |
203
+102
| +101% | +$2.97K | ﹤0.01% | 1242 |
|
|
2024
Q2 | $2.35K | Sell |
101
-8
| -7% | -$186 | ﹤0.01% | 1460 |
|
|
2024
Q1 | $2.24K | Buy |
109
+101
| +1,263% | +$2.07K | ﹤0.01% | 1313 |
|
|
2023
Q4 | $172 | Buy |
+8
| New | +$172 | ﹤0.01% | 1880 |
|
|
2023
Q3 | – | Sell |
-18
| Closed | -$531 | – | 1966 |
|
|
2023
Q2 | $531 | Buy |
+18
| New | +$531 | ﹤0.01% | 1820 |
|
|
2019
Q4 | – | Sell |
-39
| Closed | – | – | 1397 |
|
|
2019
Q3 | $0 | Buy |
+39
| New | – | ﹤0.01% | 1408 |
|